speb/financial-data huggingface dataset:
Financial ratios for 8698.T — annual report dated 2023-03-31
Total revenue: 432192192.19219226
Gross profit: 430615615.61561567
Operating income: 76253753.75375377
Net income: 25465465.465465467
Capital expenditures: 6674174.174174175
Operating cash flow: -232560060.06006008
Depreciation & amortization: 64129129.129129134
Net tangible assets: 395818318.31831837
Owner earnings: 82920420.42042042
Return on net tangible assets (%): 20.949111393509472
Capex to operating income (%): 8.752584424534803
Buffett classification: The Great
Stock price: 3.14466966966967
P/E ratio: 31.040302569893868
Shares outstanding: 251363684
Book value: 756411411.4114113
P/B ratio: 1.045007705074538
Market cap (USD): 790455753.1312313
Debt to equity: 4.125980109970821
Current ratio: 27.63695401192996
Quick ratio: 27.180633057533193
Effective tax rate (%): 22.25672877846791
Interest coverage ratio: 1.4138363028953231
COGS to revenue (%): 0.3647859922178988
SG&A to revenue (%): 81.99173151750972
Free cash flow (dilution-adjusted): -291178678.6786787
Buyback yield (%): 4.818180579332519
Retained earnings: 259076576.5765766
Inventory turnover: 0.011068943706514865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6944795813293914
FCF margin (%): -67.37249861033906
Revenue growth (%): -45.244526859278906
Rule of 40 score: -112.61702546961797
Financial ratios for 8698.T — annual report dated 2024-03-31
Total revenue: 550594294.770206
Gross profit: 549755678.8166931
Operating income: 224504754.35816166
Net income: 207838087.69149497
Capital expenditures: 5659006.867406233
Operating cash flow: 53189381.93343899
Depreciation & amortization: 53836502.9054411
Net tangible assets: 670047543.5816165
Owner earnings: 256015583.72952986
Return on net tangible assets (%): 38.20856985178177
Capex to operating income (%): 2.5206623724227177
Buffett classification: The Great
Stock price: 5.3081748547279455
P/E ratio: 6.419816510153456
Shares outstanding: 251363684
Book value: 879047807.7126255
P/B ratio: 1.51787237860535
Market cap (USD): 1334282386.8005812
Debt to equity: 0.7523944021694223
Current ratio: 65.49333627051438
Quick ratio: 60.624187685868485
Effective tax rate (%): 31.914389511925446
Interest coverage ratio: 4.295514845230575
COGS to revenue (%): 0.1523110503465976
SG&A to revenue (%): 59.0727015422993
Free cash flow (dilution-adjusted): 8993660.855784468
Buyback yield (%): 0
Retained earnings: 410268092.9741152
Inventory turnover: 0.00287284819146289
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.517761303704806
FCF margin (%): 1.633446067496582
Revenue growth (%): 27.395706057864484
Rule of 40 score: 29.029152125361065
Financial ratios for 8698.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 695475556.8006724
Buffett classification: The Gruesome
Stock price: 3.9122426110099457
Shares outstanding: 251363684
Book value: 937666339.8235049
P/B ratio: 1.0487693475168807
Market cap (USD): 983395715.4052389
Debt to equity: 0.5873692859276962
Current ratio: 23.57104581192076
Quick ratio: 22.005929634998022
Buyback yield (%): 0
Retained earnings: 436468693.0942709
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8698.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 593122577.1955621
Buffett classification: The Gruesome
Stock price: 4.516708996123513
Shares outstanding: 251363684
Book value: 843831038.6311984
P/B ratio: 1.345454908441397
Market cap (USD): 1135336612.821548
Debt to equity: 0.6892058865461693
Current ratio: 294.6291879613855
Quick ratio: 269.2572402044293
Buyback yield (%): 0
Retained earnings: 309223365.8601791
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8698.T — annual report dated 2025-03-31
Total revenue: 518827696.8319743
Gross profit: 518667290.4691886
Operating income: 108795615.55941719
Net income: -33865793.343135945
Capital expenditures: 6108808.982756316
Operating cash flow: 88891859.37708862
Depreciation & amortization: 33397941.451677583
Net tangible assets: 593122577.1955621
Owner earnings: -6576660.874214678
Return on net tangible assets (%): -1.108819850579764
Capex to operating income (%): 5.614940410369824
Buffett classification: The Great
Stock price: 4.516708996123513
Shares outstanding: 251363684
Book value: 843831038.6311984
P/B ratio: 1.345454908441397
Market cap (USD): 1135336612.821548
Debt to equity: 0.6892058865461693
Current ratio: 294.6291879613855
Quick ratio: 269.2572402044293
Interest coverage ratio: 2.387153541575011
COGS to revenue (%): 0.030917077820861293
SG&A to revenue (%): 78.99957489017996
Free cash flow (dilution-adjusted): -35349552.19890388
Buyback yield (%): 2.330618599133829
Retained earnings: 309223365.8601791
Inventory turnover: 0.0005371530886302596
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.299542295304289
FCF margin (%): -6.813351024772308
Revenue growth (%): -5.769510915744166
Rule of 40 score: -12.582861940516473
Financial ratios for 8698.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.709313589814559
Shares outstanding: 251363684
Market cap (USD): 1183750413.0470524
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8698.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 551487213.9973083
Buffett classification: The Gruesome
Stock price: 5.496567967698519
Shares outstanding: 251363684
Book value: 803391655.4508753
P/B ratio: 1.7197559426251414
Market cap (USD): 1381637573.7170928
Debt to equity: 0.9950495878844731
Current ratio: 288.37914937759336
Quick ratio: 255.57520746887965
Buyback yield (%): 0
Retained earnings: 299104979.8115747
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9302.T — annual report dated 2022-03-31
Total revenue: 2466964432.060318
Gross profit: 362874938.5346665
Operating income: 212604491.0670382
Net income: 148459268.97229964
Capital expenditures: 43755122.11112932
Operating cash flow: 189501721.02933946
Depreciation & amortization: 77372561.87510245
Net tangible assets: 579872152.1062121
Owner earnings: 182076708.73627278
Return on net tangible assets (%): 31.39945728984115
Capex to operating income (%): 20.58052578829697
Buffett classification: The Great
Stock price: 6.102524176364531
P/E ratio: 3.0741740640563067
Shares outstanding: 74787026
Book value: 726339944.271431
P/B ratio: 0.628341643390125
Market cap (USD): 456389634.2434028
Debt to equity: 1.1214627431511486
Current ratio: 1.1820418392139485
Quick ratio: 1.150792316743326
Effective tax rate (%): 29.104214769303017
Interest coverage ratio: 30.20023282887078
COGS to revenue (%): 85.2912939050359
Free cash flow (dilution-adjusted): 129995082.77331585
Buyback yield (%): 0
Retained earnings: 432322570.0704803
Inventory turnover: 125.54669926650367
Receivables turnover: 7.314275300692504
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.451487119923675
FCF margin (%): 5.269434819728987
Rule of 40 score: 5.269434819728987
Financial ratios for 9302.T — annual report dated 2023-03-31
Total revenue: 2258513513.5135136
Gross profit: 335540540.5405406
Operating income: 194909909.90990993
Net income: 140533033.03303304
Capital expenditures: 17469969.969969973
Operating cash flow: 242792792.79279283
Depreciation & amortization: 73573573.57357357
Net tangible assets: 621351351.3513514
Owner earnings: 196636636.6366366
Return on net tangible assets (%): 31.646609637040253
Capex to operating income (%): 8.963099915260766
Buffett classification: The Great
Stock price: 9.215015015015016
P/E ratio: 4.903925807652119
Shares outstanding: 74787026
Book value: 781358858.8588588
P/B ratio: 0.882006468224872
Market cap (USD): 689163567.5183184
Debt to equity: 0.8898988249084813
Current ratio: 1.4110129640216127
Quick ratio: 1.3741494089660131
Effective tax rate (%): 30.744755632838803
Interest coverage ratio: 29.807118254879448
COGS to revenue (%): 85.14396643996358
Free cash flow (dilution-adjusted): 199662162.16216218
Buyback yield (%): 0
Retained earnings: 482312312.31231236
Inventory turnover: 128.1350675337669
Receivables turnover: 9.316342014802887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.698335061530337
FCF margin (%): 8.840423622329924
Revenue growth (%): -8.449692903464923
Rule of 40 score: 0.3907307188650009
Financial ratios for 9302.T — annual report dated 2024-03-31
Total revenue: 1720754094.0306392
Gross profit: 266290279.97886953
Operating income: 137050977.28473324
Net income: 94790015.84786054
Capital expenditures: 48923666.13840465
Operating cash flow: 153037506.60327524
Depreciation & amortization: 65075277.33755943
Net tangible assets: 643786318.0137348
Owner earnings: 110941627.04701532
Return on net tangible assets (%): 17.23267859890251
Capex to operating income (%): 35.697422307877616
Buffett classification: The Good
Stock price: 10.01472530375066
P/E ratio: 7.901375635136189
Shares outstanding: 74787026
Book value: 797847332.2768093
P/B ratio: 0.9387403972851869
Market cap (USD): 748971521.6744585
Debt to equity: 0.6891066492311257
Current ratio: 1.2029042386185242
Quick ratio: 1.1704114338042908
Effective tax rate (%): 31.43894168775968
Interest coverage ratio: 26.372299872935198
COGS to revenue (%): 84.5255592096427
Free cash flow (dilution-adjusted): 77324352.87902799
Buyback yield (%): 0
Retained earnings: 473930269.4136292
Inventory turnover: 110.85354806240564
Receivables turnover: 8.611162514044016
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.254902638951338
FCF margin (%): 4.4936317831390955
Revenue growth (%): -23.810325520093762
Rule of 40 score: -19.31669373695467
Financial ratios for 9302.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 699824905.4489424
Buffett classification: The Gruesome
Stock price: 14.201218658075362
Shares outstanding: 74787026
Book value: 872748284.0733995
P/B ratio: 1.2169223685621657
Market cap (USD): 1062066909.0131673
Debt to equity: 0.6358748425098908
Current ratio: 1.1593903625051625
Quick ratio: 1.1355564141165184
Buyback yield (%): 0
Retained earnings: 529843115.28225243
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9302.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 693964710.6001871
Buffett classification: The Gruesome
Stock price: 17.526801229782116
Shares outstanding: 74787026
Book value: 867176848.0149713
P/B ratio: 1.5115455887331501
Market cap (USD): 1310777339.268547
Debt to equity: 0.6752603143039916
Current ratio: 1.4740831252545645
Quick ratio: 1.4474667516690574
Buyback yield (%): 0
Retained earnings: 521481085.41638815
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9302.T — annual report dated 2025-03-31
Total revenue: 1876353428.6860044
Gross profit: 267724903.08782247
Operating income: 119181927.54979281
Net income: 88684667.82515706
Capital expenditures: 75036759.79147172
Operating cash flow: 146377489.6404224
Depreciation & amortization: 72403422.00240609
Net tangible assets: 693964710.6001871
Owner earnings: 86051330.03609145
Return on net tangible assets (%): 12.399957623445795
Capex to operating income (%): 62.959847465231036
Buffett classification: The Good
Stock price: 17.526801229782116
P/E ratio: 14.78020238912955
Shares outstanding: 74787026
Book value: 867176848.0149713
P/B ratio: 1.5115455887331501
Market cap (USD): 1310777339.268547
Debt to equity: 0.6752603143039916
Current ratio: 1.4740831252545645
Quick ratio: 1.4474667516690574
Effective tax rate (%): 27.111941118312643
Interest coverage ratio: 22.949806949806952
COGS to revenue (%): 85.7323502172829
Free cash flow (dilution-adjusted): 54397807.779708594
Buyback yield (%): 0
Retained earnings: 521481085.41638815
Inventory turnover: 160.13639387890885
Receivables turnover: 7.866950624894916
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.964091913981377
FCF margin (%): 2.899123744389827
Revenue growth (%): 9.042508467371672
Rule of 40 score: 11.9416322117615
Financial ratios for 9302.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.910254636036534
Shares outstanding: 74787026
Market cap (USD): 2012537913.1318848
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9302.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 746695827.7254374
Buffett classification: The Gruesome
Stock price: 27.660834454912514
Shares outstanding: 74787026
Book value: 923452220.7267833
P/B ratio: 2.2401500577183455
Market cap (USD): 2068671545.561238
Debt to equity: 0.6108872290034615
Current ratio: 1.602767741495671
Quick ratio: 1.5839014247733314
Buyback yield (%): 0
Retained earnings: 550423956.9313594
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9686.T — annual report dated 2022-03-31
Total revenue: 225089600.06556302
Gross profit: 44283109.326339945
Operating income: 6957597.115227012
Net income: 3765899.0329454187
Capital expenditures: 13652179.97049664
Operating cash flow: 6424307.490575315
Depreciation & amortization: 8755974.430421242
Net tangible assets: 161802876.57761022
Owner earnings: -1130306.5071299784
Return on net tangible assets (%): -0.6985700940785292
Capex to operating income (%): 196.2197543835678
Buffett classification: The Gruesome
Stock price: 6.964268152761842
P/E ratio: 19.50235437419888
Shares outstanding: 10545817
Book value: 167567267.66103917
P/B ratio: 0.43829501132953524
Market cap (USD): 73443897.47795443
Debt to equity: 0.19766427190336877
Current ratio: 2.923589733363577
Quick ratio: 2.8533431127440596
Effective tax rate (%): 41.6335681034428
Interest coverage ratio: 19.184371681015975
COGS to revenue (%): 80.32644888576851
Free cash flow (dilution-adjusted): -10933609.244386166
Buyback yield (%): 0.0009931235267498482
Retained earnings: 70011391.57515162
Inventory turnover: 65.23727530523595
Receivables turnover: 11.316818963005938
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3870388670096743
FCF margin (%): -4.85744754142416
Rule of 40 score: -4.85744754142416
Financial ratios for 9686.T — annual report dated 2023-03-31
Total revenue: 226268866.3663664
Gross profit: 43810052.55255256
Operating income: 6341208.708708709
Net income: 5569669.66966967
Capital expenditures: 8181839.33933934
Operating cash flow: 11228183.183183184
Depreciation & amortization: 8334174.174174175
Net tangible assets: 144999692.1921922
Owner earnings: 5722004.504504504
Return on net tangible assets (%): 3.9462183801881316
Capex to operating income (%): 129.0264950292962
Buffett classification: The Gruesome
Stock price: 6.453303303303304
P/E ratio: 12.218921357712839
Shares outstanding: 10545817
Book value: 154831223.72372374
P/B ratio: 0.4395454227215055
Market cap (USD): 68055355.68213214
Debt to equity: 0.24559431394807066
Current ratio: 2.482811231227464
Quick ratio: 2.266119164387997
Effective tax rate (%): 33.06549184521012
Interest coverage ratio: 20.27287346390169
COGS to revenue (%): 80.6380520821966
Free cash flow (dilution-adjusted): 3037027.027027027
Buyback yield (%): 4.567900894855492
Retained earnings: 67350840.84084085
Inventory turnover: 19.01315864617715
Receivables turnover: 11.264158397043566
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.288125079779901
FCF margin (%): 1.3422204635566533
Revenue growth (%): 0.5239097232657005
Rule of 40 score: 1.8661301868223537
Financial ratios for 9686.T — annual report dated 2024-03-31
Total revenue: 206348692.55150554
Gross profit: 39589923.40200739
Operating income: 6381405.176967776
Net income: 4135136.0274696248
Capital expenditures: 21625898.045430534
Operating cash flow: 12546685.155837296
Depreciation & amortization: 8161991.547807713
Net tangible assets: 133173712.36133122
Owner earnings: -9328770.470153196
Return on net tangible assets (%): -7.004963896209541
Capex to operating income (%): 338.8892798013245
Buffett classification: The Gruesome
Stock price: 7.927099841521395
P/E ratio: 20.216443598003913
Shares outstanding: 10545817
Book value: 140729364.7649234
P/B ratio: 0.5940319876314134
Market cap (USD): 83597744.26941364
Debt to equity: 0.3072216639831307
Current ratio: 2.212966440597293
Quick ratio: 2.0098430606058817
Effective tax rate (%): 40.57520750874683
Interest coverage ratio: 22.911332385016593
COGS to revenue (%): 80.81406307171014
Free cash flow (dilution-adjusted): -13800990.491283678
Buyback yield (%): 2.8092401982812034
Retained earnings: 60905229.79397781
Inventory turnover: 17.073387188915728
Receivables turnover: 11.027353261260803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.392052628482769
FCF margin (%): -6.688188968214029
Revenue growth (%): -8.803762592157431
Rule of 40 score: -15.491951560371461
Financial ratios for 9686.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 123169274.40818042
Buffett classification: The Gruesome
Stock price: 7.864126628379324
Shares outstanding: 10545817
Book value: 149979086.70682168
P/B ratio: 0.5529680311351249
Market cap (USD): 82933640.28771536
Debt to equity: 0.44689267504915237
Current ratio: 1.8457071911644454
Quick ratio: 1.6802060479652845
Buyback yield (%): 0
Retained earnings: 63839018.06975767
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9686.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 119967517.71153589
Buffett classification: The Gruesome
Stock price: 8.612150781981018
Shares outstanding: 10545817
Book value: 145289754.04357708
P/B ratio: 0.6251106055003591
Market cap (USD): 90822166.12317872
Debt to equity: 0.4351432472517455
Current ratio: 1.9501883092216312
Quick ratio: 1.8957339568706255
Buyback yield (%): 0
Retained earnings: 63563367.19689881
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9686.T — annual report dated 2025-03-31
Total revenue: 233425063.49418527
Gross profit: 46185951.07605935
Operating income: 7011977.0084213335
Net income: 4629748.696698302
Capital expenditures: 3908702.0451811254
Operating cash flow: 19127817.136746425
Depreciation & amortization: 10043637.214276167
Net tangible assets: 119967517.71153589
Owner earnings: 10764683.865793344
Return on net tangible assets (%): 8.972998750942923
Capex to operating income (%): 55.743223922251914
Buffett classification: The Good
Stock price: 8.612150781981018
P/E ratio: 19.617083360906477
Shares outstanding: 10545817
Book value: 145289754.04357708
P/B ratio: 0.6251106055003591
Market cap (USD): 90822166.12317872
Debt to equity: 0.4351432472517455
Current ratio: 1.9501883092216312
Quick ratio: 1.8957339568706255
Effective tax rate (%): 47.3943334669923
Interest coverage ratio: 16.31366816980252
COGS to revenue (%): 80.21379663850522
Free cash flow (dilution-adjusted): 10556757.118032347
Buyback yield (%): 0.0013319780522539181
Retained earnings: 63563367.19689881
Inventory turnover: 63.823708989176176
Receivables turnover: 10.426324148431203
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.413152445783738
FCF margin (%): 4.5225465337809885
Revenue growth (%): 13.121658590553634
Rule of 40 score: 17.644205124334622
Financial ratios for 9686.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 131700437.41588156
Buffett classification: The Gruesome
Stock price: 10.2535666218035
Shares outstanding: 10545817
Book value: 156064360.69986543
P/B ratio: 0.6928695104118102
Market cap (USD): 108132237.19084792
Debt to equity: 0.38566490237402484
Current ratio: 1.8339308950367965
Quick ratio: 1.7893913183749348
Buyback yield (%): 0
Retained earnings: 72621473.75504711
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACAD — annual report dated 2021-12-31
Capital expenditures: 1122000
Buffett classification: The Gruesome
Stock price: 23.34
Shares outstanding: 171235870
Market cap (USD): 3996645205.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACAD — annual report dated 2022-12-31
Total revenue: 517235000
Gross profit: 507069000
Operating income: -223596000
Net income: -215975000
Capital expenditures: 0
Operating cash flow: -114035000
Depreciation & amortization: 2026000
Net tangible assets: 400413000
Owner earnings: -213949000
Return on net tangible assets (%): -53.4320813759793
Buffett classification: The Gruesome
Stock price: 15.92
Shares outstanding: 171235870
Book value: 400413000
P/B ratio: 6.8081582026557586
Market cap (USD): 2726075050.4
Debt to equity: 0.15484012756828575
Current ratio: 4.0431186818435085
Quick ratio: 3.9902969036058265
COGS to revenue (%): 1.9654509072278559
R&D to revenue (%): 69.90536216613337
SG&A to revenue (%): 71.35828008545438
Free cash flow (dilution-adjusted): -182236000
Buyback yield (%): 0
Retained earnings: -2369551000
Inventory turnover: 1.531946955997589
Receivables turnover: 8.199667089410273
Capitalized R&D asset: 361575000
ROCI (R&D-adjusted, %): 2.118828732259635
FCF margin (%): -35.2327278703104
Rule of 40 score: -35.2327278703104
Financial ratios for ACAD — annual report dated 2023-12-31
Total revenue: 726437000
Gross profit: 684799000
Operating income: -73379000
Net income: -61286000
Capital expenditures: 50000
Operating cash flow: 16702000
Depreciation & amortization: 5552000
Net tangible assets: 366265000
Owner earnings: -55784000
Return on net tangible assets (%): -15.23050250501686
Buffett classification: The Gruesome
Stock price: 31.31
Shares outstanding: 171235870
Book value: 431755000
P/B ratio: 12.417679215527324
Market cap (USD): 5361395089.7
Debt to equity: 0.1324941228242869
Current ratio: 2.4232657106672857
Quick ratio: 2.2823869044341487
COGS to revenue (%): 5.731811567968041
R&D to revenue (%): 48.4032338661164
SG&A to revenue (%): 55.96617463042218
Free cash flow (dilution-adjusted): -49769000
Buyback yield (%): 0
Retained earnings: -2430837000
Inventory turnover: 1.1624556799463972
Receivables turnover: 7.097576941866145
Capitalized R&D asset: 593874250
ROCI (R&D-adjusted, %): 3.7212521095023576
Rosenberg metric: 0.49154393970822097
FCF margin (%): -6.851110282102922
Revenue growth (%): 40.44621883669899
Rule of 40 score: 33.59510855459607
Financial ratios for ACAD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.38
Shares outstanding: 171235870
Market cap (USD): 2633607680.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACAD — quarterly report dated 2024-12-31
Capital expenditures: 453000
Buffett classification: The Gruesome
Stock price: 18.35
Shares outstanding: 171235870
Market cap (USD): 3142178214.5000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACAD — annual report dated 2024-12-31
Total revenue: 957797000
Gross profit: 875956000
Operating income: 84279000
Net income: 226451000
Capital expenditures: 523000
Operating cash flow: 157719000
Depreciation & amortization: 15883000
Net tangible assets: 613011000
Owner earnings: 241811000
Return on net tangible assets (%): 39.4464373396236
Capex to operating income (%): 0.620557908850366
Buffett classification: The Great
Stock price: 18.35
P/E ratio: 13.875753317494734
Shares outstanding: 171235870
Book value: 732793000
P/B ratio: 4.2879479123026565
Market cap (USD): 3142178214.5000005
Debt to equity: 0.07095455333225072
Current ratio: 2.3762706713601944
Quick ratio: 2.320685288829235
Effective tax rate (%): 12.253802189286061
COGS to revenue (%): 8.544712501709654
R&D to revenue (%): 31.661093112632425
SG&A to revenue (%): 50.99493942870984
Free cash flow (dilution-adjusted): 90147000
Buyback yield (%): 0
Retained earnings: -2204386000
Inventory turnover: 3.7286892341336735
Receivables turnover: 9.14845026027986
Capitalized R&D asset: 658153480
ROCI (R&D-adjusted, %): 3.3571565307559164
Rosenberg metric: 0.5436480963770445
FCF margin (%): 9.411910874642539
Revenue growth (%): 31.848598020199965
Rule of 40 score: 41.2605088948425
Financial ratios for ACAD — quarterly report dated 2025-03-31
Total revenue: 244317000
Gross profit: 223925000
Operating income: 19290000
Net income: 18987000
Capital expenditures: 0
Operating cash flow: 20323000
Depreciation & amortization: 2951000
Net tangible assets: 648177000
Owner earnings: 21938000
Return on net tangible assets (%): 3.384569338313455
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.61
P/E ratio: 37.44967347000579
Shares outstanding: 171235870
Book value: 765237000
P/B ratio: 3.716793360357641
Market cap (USD): 2844227800.7
Debt to equity: 0.07318778365395295
Current ratio: 2.8788616005024297
Quick ratio: 2.803007966152117
Effective tax rate (%): 31.64980740847403
COGS to revenue (%): 8.346533397184805
R&D to revenue (%): 32.034201467765236
SG&A to revenue (%): 51.72378508249529
Free cash flow (dilution-adjusted): -89895000
Buyback yield (%): 0
Retained earnings: -2185399000
Inventory turnover: 0.8886177444657487
Receivables turnover: 2.1485217299540955
Capitalized R&D asset: 78265000
ROCI (R&D-adjusted, %): 7.869920203267118
FCF margin (%): -36.79441054040448
Rule of 40 score: -36.79441054040448
Financial ratios for ACAD — quarterly report dated 2025-06-30
Total revenue: 264566000
Gross profit: 243832000
Operating income: 32374000
Net income: 26666000
Capital expenditures: 297000
Operating cash flow: 63956000
Depreciation & amortization: 2935000
Net tangible assets: 708044000
Owner earnings: 29304000
Return on net tangible assets (%): 4.138725841896831
Capex to operating income (%): 0.9174028541422128
Buffett classification: The Great
Stock price: 21.57
P/E ratio: 80.90503835235363
Shares outstanding: 171235870
Book value: 822382000
P/B ratio: 4.491292022320527
Market cap (USD): 3693557715.9
Debt to equity: 0.06845237371440523
Current ratio: 2.9105549899401257
Quick ratio: 2.831397110513175
Effective tax rate (%): 33.684812613463976
COGS to revenue (%): 7.83698585608128
R&D to revenue (%): 29.463725497607403
SG&A to revenue (%): 50.46264448190622
Free cash flow (dilution-adjusted): 49319000
Buyback yield (%): 0
Retained earnings: -2158733000
Inventory turnover: 0.7936763129689175
Receivables turnover: 2.2105008104540214
Capitalized R&D asset: 130388550
ROCI (R&D-adjusted, %): 5.6781255411303935
Rosenberg metric: 0.25435379799399477
FCF margin (%): 18.641473205173757
Revenue growth (%): 8.28800288150231
Rule of 40 score: 26.92947608667607
Financial ratios for ACAD — quarterly report dated 2025-09-30
Total revenue: 278633000
Gross profit: 256986000
Operating income: 35756000
Net income: 71779000
Capital expenditures: 388000
Operating cash flow: 74288000
Depreciation & amortization: 2950000
Net tangible assets: 805657000
Owner earnings: 74341000
Return on net tangible assets (%): 9.227375918039563
Capex to operating income (%): 1.0851325651638886
Buffett classification: The Great
Stock price: 21.34
P/E ratio: 31.117356987873833
Shares outstanding: 171235870
Book value: 917272000
P/B ratio: 3.983740336345163
Market cap (USD): 3654173465.8
Debt to equity: 0.05975217819796091
Current ratio: 3.0187052700065062
Quick ratio: 2.9371059834428914
Effective tax rate (%): -60.95750644691109
COGS to revenue (%): 7.7690008003359265
R&D to revenue (%): 31.52139193849975
SG&A to revenue (%): 47.876956426553924
Free cash flow (dilution-adjusted): 60720000
Buyback yield (%): 0
Retained earnings: -2086954000
Inventory turnover: 0.7439598584046465
Receivables turnover: 1.9982572899783417
Capitalized R&D asset: 165883620
ROCI (R&D-adjusted, %): 3.7047412612621025
Rosenberg metric: 0.1687470333927724
FCF margin (%): 21.792106462622876
Revenue growth (%): 5.317009744260411
Rule of 40 score: 27.109116206883286
Financial ratios for ACAD — quarterly report dated 2025-12-31
Total revenue: 283989000
Gross profit: 257764000
Operating income: 17391000
Net income: 273568000
Capital expenditures: 4005000
Operating cash flow: -48731000
Depreciation & amortization: 2924000
Net tangible assets: 1118497000
Owner earnings: 272487000
Return on net tangible assets (%): 24.361889213828917
Capex to operating income (%): 23.029153010177676
Buffett classification: The Great
Stock price: 26.71
P/E ratio: 11.697468254987212
Shares outstanding: 171235870
Book value: 1227390000
P/B ratio: 3.7263706627070454
Market cap (USD): 4573710087.7
Debt to equity: 0.042518677844857786
Current ratio: 3.8327655766218958
Quick ratio: 3.7076546114595437
Effective tax rate (%): -939.4315893460998
COGS to revenue (%): 9.234512604361436
R&D to revenue (%): 29.84517005940371
SG&A to revenue (%): 54.796488596389295
Free cash flow (dilution-adjusted): 32867000
Buyback yield (%): 0
Retained earnings: -1813386000
Inventory turnover: 0.7564176521488318
Receivables turnover: 1.9158543084779838
Capitalized R&D asset: 169326260
ROCI (R&D-adjusted, %): 1.279564252286594
Rosenberg metric: 0.008858122032586048
FCF margin (%): 11.573335586941749
Revenue growth (%): 1.9222418019401868
Rule of 40 score: 13.495577388881935
Financial ratios for ACAD — annual report dated 2025-12-31
Total revenue: 1071505000
Gross profit: 982507000
Operating income: 104811000
Net income: 391000000
Capital expenditures: 4690000
Operating cash flow: 109836000
Depreciation & amortization: 11760000
Net tangible assets: 1118497000
Owner earnings: 398070000
Return on net tangible assets (%): 35.58972442483082
Capex to operating income (%): 4.474721164763241
Buffett classification: The Great
Stock price: 26.71
P/E ratio: 11.697468254987212
Shares outstanding: 171235870
Book value: 1227390000
P/B ratio: 3.7263706627070454
Market cap (USD): 4573710087.7
Debt to equity: 0.042518677844857786
Current ratio: 3.8327655766218958
Quick ratio: 3.7076546114595437
Effective tax rate (%): -181.48937395611358
COGS to revenue (%): 8.305887513357382
R&D to revenue (%): 30.685997732161773
SG&A to revenue (%): 51.22645251305406
Free cash flow (dilution-adjusted): 53011000
Buyback yield (%): 0
Retained earnings: -1813386000
Inventory turnover: 2.567003172771849
Receivables turnover: 7.228616146420115
Capitalized R&D asset: 648013100
ROCI (R&D-adjusted, %): 5.463455239721934
Rosenberg metric: 0.35136472008151715
FCF margin (%): 4.947340423049822
Revenue growth (%): 11.871826702317923
Rule of 40 score: 16.819167125367745
Financial ratios for ALVDM.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 83.625
Shares outstanding: 4487000
Market cap (USD): 375225375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVDM.PA — annual report dated 2022-12-31
Total revenue: 529022340.4255319
Gross profit: 136042553.19148937
Operating income: 48928723.40425532
Net income: 35489361.702127665
Capital expenditures: 543617.0212765958
Operating cash flow: 57641489.36170213
Depreciation & amortization: 6124468.085106383
Net tangible assets: 56148936.17021277
Owner earnings: 41070212.76595745
Return on net tangible assets (%): 73.14513073133764
Capex to operating income (%): 1.1110386363142217
Buffett classification: The Great
Stock price: 83.67021276595746
P/E ratio: 10.57861360911271
Shares outstanding: 4487000
Book value: 150160638.29787236
P/B ratio: 2.5001774695184587
Market cap (USD): 375428244.6808511
Debt to equity: 0.9676941714901062
Current ratio: 1.6934090367053645
Quick ratio: 1.6879043860256497
Effective tax rate (%): 22.57525471720008
Interest coverage ratio: 12.291020844468198
COGS to revenue (%): 74.28415724710979
Free cash flow (dilution-adjusted): 52345744.680851065
Buyback yield (%): 0.008784294701185923
Retained earnings: 31804255.31914894
Inventory turnover: 258.1418588399721
Receivables turnover: 4.737543585541985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.495706876887432
FCF margin (%): 9.894807965717572
Rule of 40 score: 9.894807965717572
Financial ratios for ALVDM.PA — annual report dated 2023-12-31
Total revenue: 770657777.7777778
Gross profit: 195264444.44444445
Operating income: 64002222.222222224
Net income: 52154444.44444444
Capital expenditures: 3333.333333333333
Operating cash flow: 81563333.33333333
Depreciation & amortization: 7380000
Net tangible assets: 119710000
Owner earnings: 59531111.111111104
Return on net tangible assets (%): 49.72943873620508
Capex to operating income (%): 0.005208152494705045
Buffett classification: The Great
Stock price: 132.82222222222222
P/E ratio: 11.427085792198387
Shares outstanding: 4487000
Book value: 252795555.55555558
P/B ratio: 2.3575308110198843
Market cap (USD): 595973311.1111112
Debt to equity: 0.3948073981610084
Current ratio: 1.6228325117111813
Quick ratio: 1.6169953155274321
Effective tax rate (%): 24.65986667737531
Interest coverage ratio: 31.186789388197077
COGS to revenue (%): 74.66262586650365
Free cash flow (dilution-adjusted): 70747777.77777778
Buyback yield (%): 0.882403421570071
Retained earnings: 49022222.222222224
Inventory turnover: 271.9821428571429
Receivables turnover: 4.890684605024715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.06679463535198
FCF margin (%): 9.18018085560387
Revenue growth (%): 45.67584748082294
Rule of 40 score: 54.85602833642681
Financial ratios for ALVDM.PA — annual report dated 2024-12-31
Total revenue: 765906250
Gross profit: 197920833.33333334
Operating income: 64127083.333333336
Net income: 52852083.333333336
Capital expenditures: 6250
Operating cash flow: 65296875
Depreciation & amortization: 7704166.666666667
Net tangible assets: 5952083.333333334
Owner earnings: 60550000
Return on net tangible assets (%): 1017.290864543227
Capex to operating income (%): 0.009746272050940514
Buffett classification: The Great
Stock price: 141.89583333333334
P/E ratio: 12.046575347865506
Shares outstanding: 4487000
Book value: 143012500
P/B ratio: 4.451964717536346
Market cap (USD): 636686604.1666667
Debt to equity: 0.6594703260204527
Current ratio: 1.2419447850356362
Quick ratio: 1.2366119667881599
Effective tax rate (%): 24.60743124459939
Interest coverage ratio: 23.972741433021806
COGS to revenue (%): 74.15860840235561
Free cash flow (dilution-adjusted): 47143750
Buyback yield (%): 21.374657868207464
Retained earnings: 49465625
Inventory turnover: 286.22887139107615
Receivables turnover: 4.476120902200712
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.962916245111053
FCF margin (%): 6.155289893508507
Revenue growth (%): -0.6165548333890835
Rule of 40 score: 5.538735060119423
Financial ratios for ALVDM.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5952083.333333334
Buffett classification: The Gruesome
Stock price: 141.89583333333334
Shares outstanding: 4487000
Book value: 143012500
P/B ratio: 4.451964717536346
Market cap (USD): 636686604.1666667
Debt to equity: 0.6594703260204527
Current ratio: 1.2419447850356362
Quick ratio: 1.2366119667881599
Buyback yield (%): 0
Retained earnings: 49465625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVDM.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 190.69411764705885
Shares outstanding: 4487000
Market cap (USD): 855644505.8823531
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANGI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 92.1
Shares outstanding: 40448016
Market cap (USD): 3725262273.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANGI — annual report dated 2022-12-31
Total revenue: 1764355000
Gross profit: 1426959000
Operating income: -75620000
Net income: -127982000
Capital expenditures: 162000
Operating cash flow: 46402000
Depreciation & amortization: 91297000
Net tangible assets: -12670000
Owner earnings: -36847000
Buffett classification: The Gruesome
Stock price: 23.5
Shares outstanding: 40448016
Book value: 1051378000
P/B ratio: 0.9040786244338382
Market cap (USD): 950528376
Debt to equity: 0.4866109049266772
Current ratio: 1.7183445475967407
Quick ratio: 1.7183445475967407
Interest coverage ratio: -3.760879295767643
COGS to revenue (%): 19.122908938393916
R&D to revenue (%): 4.184021923025695
SG&A to revenue (%): 75.80452913387612
Free cash flow (dilution-adjusted): -119879000
Buyback yield (%): 0.8567866257997961
Retained earnings: -190079000
Receivables turnover: 24.516167132157793
Capitalized R&D asset: 73821000
ROCI (R&D-adjusted, %): -1.5534631709921374
FCF margin (%): -6.794494305284367
Rule of 40 score: -6.794494305284367
Financial ratios for ANGI — annual report dated 2023-12-31
Total revenue: 1358748000
Gross profit: 1296201000
Operating income: -26498000
Net income: -40311000
Capital expenditures: 85000
Operating cash flow: 94184000
Depreciation & amortization: 101562000
Net tangible assets: -16053000
Owner earnings: 61166000
Buffett classification: The Gruesome
Stock price: 24.9
Shares outstanding: 40448016
Book value: 1044508000
P/B ratio: 0.9642392383782604
Market cap (USD): 1007155598.4
Debt to equity: 0.4919483622911457
Current ratio: 1.8836635673000715
Quick ratio: 1.8836635673000715
Interest coverage ratio: -1.3158861796692656
COGS to revenue (%): 4.603281844757086
R&D to revenue (%): 7.105291047346528
SG&A to revenue (%): 82.76692955573807
Free cash flow (dilution-adjusted): 2990000
Buyback yield (%): 1.0854330768122553
Retained earnings: -231019000
Receivables turnover: 26.589980430528374
Capitalized R&D asset: 146003070
ROCI (R&D-adjusted, %): 0.7603395729183459
Rosenberg metric: -1.771284593814768
FCF margin (%): 0.2200555217008599
Revenue growth (%): -22.988967639732365
Rule of 40 score: -22.768912118031505
Financial ratios for ANGI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.8
Shares outstanding: 40448016
Market cap (USD): 1043558812.8000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANGI — annual report dated 2024-12-31
Total revenue: 1185112000
Gross profit: 1127534000
Operating income: 21885000
Net income: 36848000
Capital expenditures: 81000
Operating cash flow: 155941000
Depreciation & amortization: 88652000
Net tangible assets: 11699000
Owner earnings: 125419000
Return on net tangible assets (%): 1072.0488930677836
Capex to operating income (%): 0.37011651816312546
Buffett classification: The Great
Stock price: 16.6
P/E ratio: 18.221804863221887
Shares outstanding: 40448016
Book value: 1062801000
P/B ratio: 0.631761793223755
Market cap (USD): 671437065.6
Debt to equity: 0.47954791160339516
Current ratio: 2.136953012370618
Quick ratio: 2.136953012370618
Effective tax rate (%): -83.5333964237685
Interest coverage ratio: 1.0850810650007436
COGS to revenue (%): 4.858443758902112
R&D to revenue (%): 8.046496871181795
SG&A to revenue (%): 77.76792404430974
Free cash flow (dilution-adjusted): 70671000
Buyback yield (%): 4.260265252773677
Retained earnings: -195015000
Receivables turnover: 32.318298336514864
Capitalized R&D asset: 184404740
ROCI (R&D-adjusted, %): 1.6075664921936215
Rosenberg metric: -1.7470660741845603
FCF margin (%): 5.963233854690527
Revenue growth (%): -12.77911724617074
Rule of 40 score: -6.815883391480213
Financial ratios for ANGI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.6
Shares outstanding: 40448016
Market cap (USD): 671437065.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANGI — quarterly report dated 2025-03-31
Total revenue: 245913000
Gross profit: 232898000
Operating income: 20003000
Net income: 15106000
Capital expenditures: 75000
Operating cash flow: -3113000
Depreciation & amortization: 9948000
Net tangible assets: -4619000
Owner earnings: 24979000
Return on net tangible assets (%): -540.7880493613336
Capex to operating income (%): 0.37494375843623456
Buffett classification: The Great
Stock price: 15.41
P/E ratio: 10.315502557924004
Shares outstanding: 40448016
Book value: 1049040000
P/B ratio: 0.5941660247083047
Market cap (USD): 623303926.5600001
Debt to equity: 0.4738055746206055
Current ratio: 2.1532415957343405
Quick ratio: 2.1532415957343405
Effective tax rate (%): 23.656946480012127
Interest coverage ratio: 3.9657018239492468
COGS to revenue (%): 5.2925221521432375
R&D to revenue (%): 11.014871112954582
SG&A to revenue (%): 71.51309609496042
Free cash flow (dilution-adjusted): -13400000
Buyback yield (%): 1.5724271230074698
Retained earnings: -179909000
Receivables turnover: 6.075676343421866
Capitalized R&D asset: 27087000
ROCI (R&D-adjusted, %): 2.354429440110852
FCF margin (%): -5.4490815857640715
Rule of 40 score: -5.4490815857640715
Financial ratios for ANGI — quarterly report dated 2025-06-30
Total revenue: 278221000
Gross profit: 265079000
Operating income: 17673000
Net income: 10897000
Capital expenditures: 0
Operating cash flow: 57121000
Depreciation & amortization: 10278000
Net tangible assets: -56638000
Owner earnings: 21175000
Return on net tangible assets (%): -37.386560259896186
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.26
P/E ratio: 23.737135105949314
Shares outstanding: 40448016
Book value: 1002224000
P/B ratio: 0.6158670358722201
Market cap (USD): 617236724.16
Debt to equity: 0.49614457446638677
Current ratio: 1.7879202265411331
Quick ratio: 1.7879202265411331
Effective tax rate (%): 37.52078435869503
Interest coverage ratio: 3.4989111067115424
COGS to revenue (%): 4.7235830508840095
R&D to revenue (%): 8.480308819248007
SG&A to revenue (%): 76.74977805413683
Free cash flow (dilution-adjusted): 39817000
Buyback yield (%): 10.787595325053902
Retained earnings: -169012000
Receivables turnover: 6.208765704849256
Capitalized R&D asset: 41742290
ROCI (R&D-adjusted, %): 1.5400522463988309
Rosenberg metric: 1.1880606933215196
FCF margin (%): 14.311284913791555
Revenue growth (%): 13.137979692004894
Rule of 40 score: 27.44926460579645
Financial ratios for ANGI — quarterly report dated 2025-09-30
Total revenue: 265633000
Gross profit: 253173000
Operating income: 21782000
Net income: 10605000
Capital expenditures: 0
Operating cash flow: 20981000
Depreciation & amortization: 11918000
Net tangible assets: -64447000
Owner earnings: 22523000
Return on net tangible assets (%): -34.94809688581315
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.26
P/E ratio: 17.965601512237765
Shares outstanding: 40448016
Book value: 994070000
P/B ratio: 0.6616080760509824
Market cap (USD): 657684740.1600001
Debt to equity: 0.5004245173881116
Current ratio: 1.892642925174809
Quick ratio: 1.892642925174809
Effective tax rate (%): 49.0217757054271
Interest coverage ratio: 4.297100019727757
COGS to revenue (%): 4.6906822570990805
R&D to revenue (%): 7.811152981745491
SG&A to revenue (%): 74.81148803047815
Free cash flow (dilution-adjusted): -1049000
Buyback yield (%): 3.9944670137258846
Retained earnings: -158104000
Receivables turnover: 6.925822599989571
Capitalized R&D asset: 45495690
ROCI (R&D-adjusted, %): 1.1866370833729465
Rosenberg metric: -0.5046198185979486
FCF margin (%): -0.3949057534267203
Revenue growth (%): -4.524460770394758
Rule of 40 score: -4.919366523821479
Financial ratios for ANGI — annual report dated 2025-12-31
Total revenue: 1030535000
Gross profit: 983099000
Operating income: 78195000
Net income: 43832000
Capital expenditures: 145000
Operating cash flow: 105073000
Depreciation & amortization: 47119000
Net tangible assets: -129842000
Owner earnings: 90806000
Return on net tangible assets (%): -69.93576808736772
Capex to operating income (%): 0.18543385126926273
Buffett classification: The Great
Stock price: 12.93
P/E ratio: 11.931758689541885
Shares outstanding: 40448016
Book value: 927366000
P/B ratio: 0.5639551664391405
Market cap (USD): 522992846.88
Debt to equity: 0.5511599519499313
Current ratio: 1.647119646822935
Quick ratio: 1.647119646822935
Effective tax rate (%): 29.899083595886577
Interest coverage ratio: 3.8201670819287705
COGS to revenue (%): 4.6030459906747465
R&D to revenue (%): 8.477247255066542
SG&A to revenue (%): 74.75961515135342
Free cash flow (dilution-adjusted): 30715000
Buyback yield (%): 28.427922272159396
Retained earnings: -150880000
Receivables turnover: 31.1773159073032
Capitalized R&D asset: 183111390
ROCI (R&D-adjusted, %): 4.41597636973678
Rosenberg metric: -1.5146287751677852
FCF margin (%): 2.980490715987327
Revenue growth (%): -13.043239795057346
Rule of 40 score: -10.06274907907002
Financial ratios for ANGI — quarterly report dated 2025-12-31
Total revenue: 240768000
Gross profit: 231949000
Operating income: 18737000
Net income: 7224000
Capital expenditures: 70000
Operating cash flow: 30084000
Depreciation & amortization: 14975000
Net tangible assets: -129842000
Owner earnings: 22129000
Return on net tangible assets (%): -17.0430215184609
Capex to operating income (%): 0.37359235736777496
Buffett classification: The Great
Stock price: 12.93
P/E ratio: 11.931758689541885
Shares outstanding: 40448016
Book value: 927366000
P/B ratio: 0.5639551664391405
Market cap (USD): 522992846.88
Debt to equity: 0.5511599519499313
Current ratio: 1.647119646822935
Quick ratio: 1.647119646822935
Effective tax rate (%): -60.67615658362989
Interest coverage ratio: 3.5319509896324224
COGS to revenue (%): 3.6628621743753325
R&D to revenue (%): 6.616743088782561
SG&A to revenue (%): 75.71853402445508
Free cash flow (dilution-adjusted): 5347000
Buyback yield (%): 8.799164324050306
Retained earnings: -150880000
Receivables turnover: 7.284080595389363
Capitalized R&D asset: 37618850
ROCI (R&D-adjusted, %): 0.9746700461617599
Rosenberg metric: -1.0228926695262421
FCF margin (%): 2.2208100744284955
Revenue growth (%): -9.360659255438895
Rule of 40 score: -7.1398491810103994
Financial ratios for BAP.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.774436090225564
Shares outstanding: 672753078
Market cap (USD): 3884769653.4135337
Buyback yield (%): 0.027986679832031923
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BAP.AX — annual report dated 2022-06-30
Total revenue: 1270279310.3448277
Gross profit: 592716551.7241379
Operating income: 134575172.41379312
Net income: 86730344.8275862
Capital expenditures: 19326896.55172414
Depreciation & amortization: 61229655.172413796
Net tangible assets: 214635172.41379312
Owner earnings: 128633103.44827586
Return on net tangible assets (%): 59.931045784185514
Capex to operating income (%): 14.361413182735966
Buffett classification: The Great
Stock price: 3.8758620689655174
P/E ratio: 30.064427185012608
Shares outstanding: 672753078
Book value: 753280689.6551723
P/B ratio: 3.4615226071886016
Market cap (USD): 2607498136.8
Debt to equity: 0.5490566780528758
Current ratio: 2.41904693472825
Quick ratio: 0.8707814790331388
Effective tax rate (%): 29.495962534113502
Interest coverage ratio: 24.00467462172469
COGS to revenue (%): 53.33966735526533
SG&A to revenue (%): 24.641716049416228
Free cash flow (dilution-adjusted): 32704827.586206898
Buyback yield (%): 0
Retained earnings: 151646896.55172414
Inventory turnover: 1.8238126707853153
Receivables turnover: 9.333520824148817
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.872028327284786
FCF margin (%): 2.5746170405096898
Rule of 40 score: 2.5746170405096898
Financial ratios for BAP.AX — annual report dated 2023-06-30
Total revenue: 1338500000
Gross profit: 625039735.0993377
Operating income: 114715231.78807947
Net income: 70495364.23841059
Capital expenditures: 20545695.36423841
Depreciation & amortization: 64011258.27814569
Net tangible assets: 215466887.41721854
Owner earnings: 113960927.15231788
Return on net tangible assets (%): 52.8902275975473
Capex to operating income (%): 17.910172035561715
Buffett classification: The Great
Stock price: 3.7218543046357615
P/E ratio: 35.51849070306629
Shares outstanding: 672753078
Book value: 745102649.0066224
P/B ratio: 3.3604617332248994
Market cap (USD): 2503888939.3112583
Debt to equity: 0.570984041489461
Current ratio: 2.260274261158975
Quick ratio: 0.8919728055947591
Effective tax rate (%): 28.46092165463893
Interest coverage ratio: 11.77646338976137
COGS to revenue (%): 53.302970855484666
SG&A to revenue (%): 25.641829961877853
Free cash flow (dilution-adjusted): 114161589.4039735
Buyback yield (%): 0
Retained earnings: 166665562.9139073
Inventory turnover: 2.0731383464926036
Receivables turnover: 8.818754199645703
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.114499025161292
FCF margin (%): 8.529069062680128
Revenue growth (%): 5.370526710118051
Rule of 40 score: 13.899595772798179